ISTH2023_HORIBA_Medical_HERO_IMAGE

ISTH 2023 - HORIBA Medical

This year again, HORIBA Medical will participate in the ISTH 2023 which will take place from June 24 to 28 in Montreal. The International Society on Thrombosis and Haemostasis (ISTH) Annual Congress is the premier event in the field of thrombosis and hemostasis featuring the latest scientific breakthroughs and clinical updates. This conference brings together researchers, physicians and biologists specialized in hemostasis, usually between 5,000 and 10,000 attendees. During this Congress, HORIBA Medical will open an exhibition booth (booth #1630) to showcase the latest innovations in hemostasis, and host a supported symposia where three key opinion leaders will talk about current scientific medical topics.

The HORIBA Medical team is looking forward to welcoming you there!

Saturday, June 24, 11:30-12:45, Room 516

Supported Symposia by HORIBA Medical

"Current Advanced in Deficient Factors, Heparin Testing and HIL"

Moderator:

Dr. Steve KITCHEN

Dr. Steve KITCHEN

Lead Clinical Scientist, Department of Coagulation, Sheffield Haemophilia and Thrombosis Centre - UK

Presenter:

Dr. Emmanuelle JEANPIERRE

Dr. Emmanuelle JEANPIERRE

Hematology Transfusion Institute of Lille University Hospital - France

Presenter:

Mr. Kevin HORNER

Mr. Kevin HORNER

Department of Coagulation, Sheffield Haemophilia and Thrombosis Centre - UK

Presenter:

Prof. Corinne FRERE

Prof. Corinne FRERE

Biological Hematology Department of Pitié-Salpêtrière University Hospital – France

1. Dr. Emmanuelle JEANPIERRE
Hematology Transfusion Institute of Lille University Hospital - France 

Sensitivity of three new Prothrombin Time reagent to extrinsic pathway factor deficiencies. 

Prothrombin time is widely used for monitoring vitamin K antagonist-based anticoagulant therapy but also as a screening test for extrinsic factor deficiency (congenital or acquired). The sensitivity of three new reagents (Yumizen G PT 5, Yumizen G PT Reco, and Yumizen G PT Liq ) was compared with that of two other reagents available in the laboratory (STA-Neo R and STA-NeoPTimal). For all five reagents, the analyses were performed on Yumizen G1550 and STAGO STA-R Max 2 to compare the performance of each reagent/instrument combination.

 

2. Mr. Kevin HORNER
Department of Coagulation, Sheffield Haemophilia and Thrombosis Centre - UK

Evaluation of the new Preanalytical HIL (Haemolysis, Icterus & Lipemia) on HORIBA Medical analysers.

Haemolysis, Icterus and Lipemia have been reported to cause interference in haemostasis assays, which may unpredictably vary between different reagent analyser combinations. The ability to determine each indice is a mainstay for determining sample quality. We report on findings of our evaluation looking at both spurious and native samples.

 

3. Prof. Corinne FRERE
Biological Hematology Department of Pitié-Salpêtrière University Hospital – France

Performance evaluation of the ACTICHROME Heparin Anti-Xa™ assay for the quantitative determination of UFH and LMWH plasma concentrations.

The ACTICHROME Heparin Anti-Xa™ assay (HORIBA Medical) is a newly launched, specific, easy to use and fully automated chromogenic assay for the quantitative determination of plasma concentrations of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). We report on findings of our evaluation of this new reagent.

Hemostasis Yumizen G Range

Yumizen G1550/G1500
Yumizen G1550/G1500

Hemostasis Analyzer

Yumizen G1500h/G1550h
Yumizen G1500h/G1550h

Hemostasis Analyzer

Yumizen G800
Yumizen G800

Hemostasis Analyzer

Yumizen G800h/G850h
Yumizen G800h/G850h

Hemostasis Analyzer

Yumizen G400
Yumizen G400

Hemostasis Analyzer

Yumizen G200
Yumizen G200

Hemostasis Analyzer

Screening Tests
Screening Tests

Hemostasis Reagents

Anticoagulant Monitoring
Anticoagulant Monitoring

Hemostasis Reagents

Factor Deficient Plasmas
Factor Deficient Plasmas

Hemostasis Reagents

Thrombophilia
Thrombophilia

Hemostasis Reagents

Wniosek o udzielenie informacji

Masz pytania lub prośby? Skorzystaj z tego formularza, aby skontaktować się z naszymi specjalistami.

* Te pola są obowiązkowe.

Corporate